LOS ANGELES and LAS VEGAS, April 12, 2016 -- Family Room Entertainment Corp. (OTC Markets:FMYR), has secured certain distribution and production, co- production and media entertainment rights of the iconic Motion Picture “Kingdom of the Spiders”. This applies to both original and all futures rights.
In early 2016, Stanley Tepper, Director/COO/CFO of Family Room Entertainment Corp. (“FMYR”) arranged for FMYR to acquire certain rights including all 3D Rights of “Kingdom of the Spiders” from Executive Producer/Producer Igo Kantor. Mr. Tepper states that “Kingdom of the Spiders was a classic cult horror of the more memorable ‘nature on the rampage’ subgenre of science fiction/horror films from the 1970’s, and will add true value to our collection.” Kingdom of the Spiders, released in 1977, starred William Shatner, was executive produced by Igo Kantor and his Kanopy Co and Arachnoids and Directed by John ”Bud” Cardos.
The Agreement for Kingdom of the Spiders (“KOS”) includes all domestic distribution rights of the original film except DVD rights at the present time. In addition, FMYR maintains all-inclusive KOS Main Distribution, current and future Production/Co-Production, Sequels, Remakes, Reality TV, Cable, Internet Streaming, etc. Also included are any contacts/ventures, for script/synopsis, plus extended material or new versions in all areas of Media Entertainment Industry.
About Family Room Entertainment Corp
Family Room Entertainment Corp is engaged in various aspects of the media entertainment inclusive of motion pictures, music including film, television and social media, internet, all aspects and verticals. It also provides production, co-production, and production/distribution and film finance services. The company also owns and manages a small library of feature films, which it continues to distribute via its FMLY/Distro/sm and which can be found at “www.fmlyroom.com” along with the Company history of feature films it has completed and/or has been involved in.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Contact Information: Email: at [email protected] Phone Number: 818-802-0060


BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Italy Fines Apple €98.6 Million Over App Store Dominance
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



